Inspiring young scientists

The fight against malaria

You'll outgrow some childhood habits, but vaccination is for life

Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them.

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

Wednesday 10 May 2017 marks World Lupus Day and patient organisations around the world will be supporting the World Lupus Federation’s ‘Lupus Knows No Boundaries’ campaign.

From TV to tackling lupus: why Alex moved from media to medicine

Alex Liakos on becoming a lupus medic, and listening to the patient

Giving a bit back – Christine’s experience of clinical research

The race against malaria: handing the baton to the next generation

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Setting the record straight: Why we publish data both positive and negative

Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.

Making the switch: how we’re improving access to proven medicines

Switching a medicine from prescription to over-the-counter places the power of managing everyday health conditions with the patient.

Healthcare in your pocket

We are dedicated to supporting patients beyond the medicines we provide and believe that digital technology, has an important role to play in this.

On target for a new era of drug discovery?

Supporting community health across the UK

30 years and counting: the fight against HIV

How to find a treatment for a disease with no idea what that disease actually is.

HIV research focus on finding a cure

With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge.

What are Bioelectronics

We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.

Live every breath

GSK have been innovating to fight respiratory disease for over 45 years.

Vaccines: the most successful health intervention… ever

Joining forces to fight malaria

STEM inspiring real world scientists

GSK STEM Education brings real world science to life in the classroom.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

A day aimed at raising awareness of COPD, a chronic disease of the lungs, which affects around 329 million people worldwide.

Taking action to stop pneumonia

Getting on target in autoimmune diseases

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Maternal immunisation: Helping protect mums and babies

Maternal immunisation: Helping protect mums and babies

Can social media help us hear patients?

Whether it’s rating their healthcare provider or discussing their medicines.

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Don’t forget the pharmacists

Rabies – Educate, Vaccinate, Eliminate.

Partnership for Prevention

Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.

Scientists or detectives? Seeking new clues in COPD

Scientists or detectives? Seeking new clues in COPD

Collaboration: unlocking a new approach to clinical trials

Collaboration: unlocking a new approach to clinical trials

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

A new response to humanitarian crises

A partnership that is all about the chemistry

Can an iPhone transform the way we monitor and improve patient health?

GSK is using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Engineering a successful career

Celebrating UK National Women in Engineering Day, Suzanne talks about the importance of networks, facing adversity and embracing your weaknesses.

Inhaler innovation: more than a simple piece of plastic

From microscope to telescope and beyond – exploring with NASA's CASIS

Meet Baby Mckline: a special delivery from our Save the Children partnership

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

Groundswell: 2016 GSK IMPACT Awards Overall Winner

Age UK South Lakeland: 2016 GSK IMPACT Award winner

Promoting a More Inclusive Society (PAMIS): 2016 GSK IMPACT Award winner

PAMIS is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with The King’s Fund.

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Body & Soul: 2016 GSK IMPACT Award winner

Body & Soul is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with The King’s Fund.

Turning the tide on antibiotic resistance

Turning the tide on antibiotic resistance.

Guardian article: The 30-year quest for a malaria vaccine

Clinical Trials: Q&A with Murray Stewart

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Living with severe asthma

What does today look like for you? Perhaps you’ll get up, head to work, meet friends for dinner – and then home to bed, so you are ready and refreshed to do it all again tomorrow.

Respiratory disease: why we want to make a difference

Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

The power of partnerships: transforming vaccine coverage in Mozambique

The value of vaccination

According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives.

A story by numbers - Meningococcal Disease

Meningococcal disease, commonly called meningitis, is a sudden, potentially life-threatening illness.

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Playing the innovation game

Living with lupus – a patient perspective

Does the relationship between the pharmaceutical industry and healthcare professionals need to change?

We have made a number of changes to how we interact with healthcare professionals (HCPs), including how we incentivise our pharmaceutical sales representatives, how we support medical education and stopping payments to external HCPs to speak on our behalf about our prescription medicines.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

Helping to further science and research – Howard’s perspective

The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life.

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

Bioelectronics at SXSW 2016

10 years from now - how will we fight disease?

10 years from now - how will we fight disease?

Working towards the development of bioelectronic medicines

Our Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.

Delivering support for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

Guardian article: Community health is crucial

The King’s Fund is a charity focused on improving healthcare in the UK. In partnership with GSK, The King’s Fund manages the annual GSK IMPACT Awards.

School leading the way to inspire young scientists

The Telegraph Open Series article: Why don't more females choose STEM careers?

The Telegraph Open Series - Vivienne Parry OBE with Nikki Yates: Should there be positive gender discrimination in science?

The Telegraph Open Series

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

GSK’s Patrick Vallance on a new generation antibiotics

GSK’s President of Pharmaceutical R&D explains why GSK is involved in challenging antibiotics resistance.

Will money alone help save a million lives?

Will money alone help save a million lives?

Rare diseases are not that rare

Rare diseases: unscrambling the code

If there are no scientists, who will cure diseases?

By 2020 the UK could be short of 1.3 million scientists. See how GSK find new ways to inspire the next generation of scientists.

20 years of support: GSK IMPACT Awards

See how we are committed to helping charities through the GSK IMPACT Awards.

Rare Disease Day: What it means to us

Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.

GSK’s President of Pharmaceutical R&D discusses the challenges of discovering new medicines on BBC Radio 4

Patrick Vallance is something of a rare breed: a game-keeper turned poacher; an academic who's moved over into industry. And not just any industry, but the pharmaceutical industry.

Explore full animation: See how we have developed the world's first malaria vaccine

Alzheimer’s Support: 2015 GSK IMPACT Award winner

RESTORE: 2015 GSK IMPACT Award overall winner

RESTORE is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

The Junction: 2015 GSK IMPACT Award winner

The Junction is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

Neuromuscular Centre: 2015 GSK IMPACT Award winner

Neuromuscular Centre in Cheshire is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

On-the-ground support to save children's lives

Find out how we are doing more than just giving money.

Telegraph article: Science hasn't answered all the questions on HIV

The Global Pain Index: an insight into the world of pain

Telegraph article: On the job with GSK's medical device development team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.

Guardian article: Igniting a revolution in scientific research and development

Innovative partnerships between science, business and charities could help tackle some of the most challenging healthcare issues, transforming the prospects of developing countries.

The benefits of receiving a 'charitable Oscar'

Jennifer Fear, CEO of Step Forward, describes how she and her charity benefited from winning a GSK IMPACT Award.

Volunteering in Kenya: a once in a lifetime experience

PULSE volunteer, Mizanul Islam shares his experience of working with Save the Children in Bungoma County, Kenya for six months in 2015.

Guardian article: Making a change from the inside

Guardian article: A different way of doing business to support Kenyan mothers

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Guardian article: Finding new ways to give mothers and newborns a healthier start

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

Malaria: Key facts

Malaria: Key facts

Disclosing information on payments to doctors has already had positive effects in Europe

Find out how we will be publicly disclosing information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs).

Malaria in numbers

Turning waste into a resource

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos

Andrew Witty speaks to Bloomberg's Jonathan Ferro and Hans Nichols on "Countdown" from the World Economic Forum in Davos, Switzerland, January 2016.

Save the Children: Key facts

Save the Children: Key facts

Intrapreneurship: keeping our fingers on the PULSE

Turbocharging the effect of vaccines

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Outgrowing asthma

We have embarked on a pioneering new asthma remission study at the Centre for Therapeutic Target Validation.

TEDMED 2015: An interview with curator, Christine McNab

We interview Christine McNab, curator of The Art of Saving a Life.

STEM in the real world

TEDMED 2015: Art, inspired by vaccination

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

War and peace: Ivo, Nobel prize winner

In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Telegraph article: Alternative routes into Science

GSK apprenticeships offer students keen on a career in science an alternative to the traditional university pathway.

Rare diseases: Q&A with Martin Andrews

Less is more with advanced technologies in manufacturing

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

The science behind sport

The state-of-the-art facility where scientists are using cutting-edge technology to examine body and brain function.

Targeting the immune system through open innovation

A functioning immune system is crucial to our health. We have discovered that its role goes beyond such things as keeping colds at bay & fighting infections.

To challenge. To change.

Health workers fighting it on the frontline

No 'silver bullet' to tackle this disease

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

On the frontline of Ebola prevention

Read how Robbie worked on the ground to fight Ebola.

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

Making our vaccines more accessible

How we are innovating to reach our goal

Lisa Bonadonna, head of the partnership at GSK, talks about a product innovation under development.

Vaccines - coming in from the cold

‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges.

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Every breath you take: Alison’s story

Imagine if every breath you took was a struggle; imagine waking up in the night short of breath and wheezing.

Cell and gene therapy: a new era of medicine

Fighting Ebola highlights the need for more health workers

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Why our transaction with Novartis is different

What makes GSK’s recently completed transaction with Novartis different?

Ebola vaccine R&D

Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate.

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Our humanitarian response to the Ebola outbreak

A healthier future for Africa

A word to the WISE (Women in science and engineering)

Anna Shaw is a Laboratory Analyst apprentice within our manufacturing organisation, based at our Ulverston site.

Employee volunteering gets personal

Peter Albert couldn’t have known how instrumental his expertise would be in helping fight the Ebola outbreak.

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

Understanding human performance

Flonase: the journey from prescription to OTC

Africa’s fight against malaria: how mothers are helping on the ground

In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

From academia to industry

Patrick Vallance talks about how he went from leading an academic department to his current role heading up our R&D operations.

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

Science of a different stripe

Inhaler recycling

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Data transparency

We have a long-standing commitment to data transparency.

Inside the Open Lab

Learn how the Tres Cantos Open Lab offers top international scientists and academics the opportunity to pursue their own projects as part of an integrated team.

Neuroscience: on the brain

The 'baby bubble'

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Novamin - the accidental curist

One of the more compelling aspects of scientific research is the unexpected avenues down which it can lead.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Algueta's smile: fighting lymphatic filariasis

Life after polio: Fatiha's story